Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 81735 | 1-Cbz-3-aminopyrrolidine hydrochloride | 1159822-27-1 | 98% |  |
| Coming soon! | ||||
| 81309 | 2-Cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde | 121660-37-5 | 98% | quinoline-3-carbaldehyde-cas-121660-37-5.png) |
| Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E | ||||
| 81308 | [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido | 154057-58-6 | 98% | -quinolin-3-ylmethyl]-triphenyl-phosphoniumbromido-cas-154057-58-6.png) |
| Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E | ||||
| 81307 | 2-Cyclopropyl-3-[(diphenylphosphinyl)methyl]-4-(4-fluorophenyl)quinolin | 146578-99-6 | 98% | methyl]-4-(4-fluorophenyl)quinolin-cas-146578-99-6.png) |
| Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E | ||||
| 81305 | (2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methanol | 121660-11-5 | 98% | quinolin-3-yl)methanol-cas-121660-11-5.png) |
| Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E | ||||
| 81004 | 3-Chloro-4-methoxybenzaldehyde | 4903-09-7 | 97% |  |
| Cooming soon! | ||||
| 73105 | CEP-33779 | 1257704-57-6 | 97% |  |
| CEP33779 is a selective JAK2 inhibitor with IC50 of 1.8 nM. CEP33779(< 3 M) inhibi | ||||
| 73104 | CID755673 | 521937-07-5 | 97% |  |
| CID 755673 is a selective and potent protein kinase D1-D3, PKC, CAK, PLK1 and CAMKII | ||||
| 73103 | CGI-1746 | 910232-84-7 | 97% |  |
| CGI1746 is a potent and highly selective small-molecule inhibitor of the Btk with IC5 | ||||
| 72804 | CPI-169(racemate) | 1450655-76-1 | 97% |  |
| CPI-169 racemate is the racemate form of CPI-169, which is a novel and potent EZH2 in | ||||
| 72001 | CHZ868(CHZ-868) | 1895895-38-1 | 98% by HPLC | -cas-1895895-38-1.png) |
| CHZ868,a type II JAK inhibitor, would demonstrate activity in JAK inhibitor persisten | ||||
| 71805 | Capivasertib ( AZD5363 ) | 1143532-39-1 | 98% |  |
| Capivasertib is a novel pyrrolopyrimidine derivative, and an orally available inhibit | ||||
| 60701 | CO-1686(Rociletinib) | 1374640-70-6 | 98% | -cas-1374640-70-6.png) |
| CO-1686(Rociletinib) is an irreversible inhibitor of epidermal growth factor receptor | ||||
| 52782 | Coluracetam | 135463-81-9 | 98% |  |
| Coluracetam(MKC-231) is a new choline uptake enhancer. | ||||
| 52781 | Chenodeoxycholic Acid | 474-25-9 | 98% |  |
| Chenodeoxycholic Acid (CDCA), is a hydrophobic primary bile acid that activates nucle | ||||
| 52780 | Cerdulatinib (PRT062070, PRT2070) | 1369761-01-2 | 98% | |
| Cerdulatinib (PRT-062070) is an oral active, multi-targeted tyrosine kinase inhibitor | ||||
| 52779 | Cediranib | 288383-20-0 |  | |
| Cediranib (AZD2171) is a highly potent VEGFR(KDR) inhibitor with IC50 of <1 nM, al | ||||
| 52778 | Cabozantinib S-malate | 1140909-48-3 | 98% |  |
| Cabozantinib S-malate (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0 | ||||
| 52777 | Cabozantinib | 849217-68-1 | 98% |  |
| Cabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM a | ||||
| 52748 | CX-5461 | 1138549-36-6 | 98% |  |
| CX-5461 is an inhibitor of rRNA synthesis, selectively inhibits Pol I-driven transcri | ||||
| 52735 | CZC24832 | 1159824-67-5 | 98% |  |
| CZC24832 is a selective inhibitor of PI 3-kinase (IC50 = 1.0 M in a PI 3-K-dependent | ||||
| 52724 | Canagliflozin | 842133-18-0 | 98% |  |
| Canagliflozin(JNJ 28431754; TA 7284) is a highly potent and selective SGLT2 inhibitor | ||||
| 52705 | CAY10603 | 1045792-66-2 | 98% |  |
| CAY10603 is a potent and selective inhibitor of HDAC6 with IC50 of 2 pM, as compared | ||||
| 52635 | CCT128930 | 885499-61-6 | 98% |  |
| CCT128930 is a novel potent ATP-competitive, selective Akt2 inhibitor with an IC50 of | ||||
| 52610 | CDK4-IN-1 | 1256963-02-6 | 98% | |
| CDK4 inhibitor is a novel and specific CDK4/Cyclin D1 inhibitor with an IC50 of 10 nM | ||||
| 52608 | Carfilzomib | 868540-17-4 | 98% |  |
| Carfilzomib (PR-171) is an irreversible proteasome inhibitor with IC50 of <5 nM. | ||||
| 52566 | CZC-54252 | 1191911-27-9 | 98% |  |
| CZC-54252 is a potent inhibitor of LRRK2 with IC50s of 1.28 nM and 1.85 nM for wild-t | ||||
| 52544 | CK-636 | 442632-72-6 | 98% |  |
| CK-636(CK-0944636) is a small molecule inhibitor of Arp2/3 complex; Inhibitor of acti | ||||
| 52534 | CYT387 | 1056634-68-4 | 98% |  |
| CYT387(momelotinib) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 11 nM/1 | ||||
| 52532 | CID 2011756 | 638156-11-3 | 98% |  |
| CID-2011756 is a cell-active ATP competitive and specific PKD1 inhibitor that inhibit | ||||